Departments of Radiology, Mayo Clinic, Rochester, Minnesota, USA.
AJNR Am J Neuroradiol. 2011 Aug;32(7):1232-6. doi: 10.3174/ajnr.A2478. Epub 2011 May 5.
The use of stents for treatment of morphologically unfavorable, acutely ruptured aneurysms is avoided by most operators because of concerns about the risk of using dual antiplatelet therapy in the setting of acute SAH. Our aim was to review the literature regarding stent-assisted coil embolization of acutely ruptured intracranial aneurysms to determine the safety and efficacy of this treatment option.
Articles including ≥5 patients with ruptured aneurysms who were treated acutely with stent-assisted coiling or uncovered stent placement alone were identified. Data on clinical presentation, technical success, surgical crossover, intracranial complications, and clinical outcome were evaluated.
A total of 17 articles were identified reporting 339 patients who met inclusion criteria. Among 212 patients with available data, technical success was noted in 198 (93%) patients. Three hundred twenty-six (96%) of 339 patients received both heparin during the procedure and dual-antiplatelet therapy during or immediately postprocedure. One hundred thirty (63%) of 207 aneurysms were completely occluded. Six (2%) of 339 patients required surgical crossover, usually for failure in stent placement or for intraprocedural aneurysm rupture. Clinically significant intracranial hemorrhagic complications occurred in 27 (8%) of 339 patients, including 9 (10%) of 90 patients known to have EVDs who had ventricular drain-related hemorrhages. Clinically significant thromboembolic events occurred in 16 (6%) of 288 patients. Sixty-seven percent of patients had favorable clinical outcomes, 14% had poor outcomes, and 19% died.
Stent-assisted coiling in ruptured aneurysms can be performed with high degrees of technical success, but adverse events appear more common and clinical outcomes are likely worse than those achieved without stent assistance. Thromboembolic complications appear reasonably well-controlled. Reported EVD-related hemorrhagic complications were uncommon, though the total number of EVDs placed was unknown.
由于担心在急性蛛网膜下腔出血(SAH)情况下使用双联抗血小板治疗的风险,大多数术者避免使用支架治疗形态学上不利的急性破裂动脉瘤。我们旨在回顾关于支架辅助弹簧圈栓塞急性破裂颅内动脉瘤的文献,以确定这种治疗选择的安全性和有效性。
确定了包括≥5 例接受支架辅助弹簧圈栓塞或单纯未覆盖支架放置治疗的急性破裂动脉瘤患者的文章。评估了临床表现、技术成功率、手术交叉、颅内并发症和临床结果的数据。
共确定了 17 篇报告符合纳入标准的 339 例患者的文章。在 212 例有可用数据的患者中,198 例(93%)患者技术成功率。339 例患者中 326 例(96%)在手术过程中接受肝素,在手术过程中或手术后立即接受双联抗血小板治疗。207 例动脉瘤中有 130 例(63%)完全闭塞。339 例患者中有 6 例(2%)需要手术交叉,通常是由于支架放置失败或术中动脉瘤破裂。339 例患者中有 27 例(8%)发生有临床意义的颅内出血性并发症,包括 9 例(10%)已知有 EVD 的 90 例患者发生与脑室引流相关的出血。288 例患者中有 16 例(6%)发生有临床意义的血栓栓塞事件。67%的患者有良好的临床结果,14%的患者预后较差,19%的患者死亡。
在破裂动脉瘤中使用支架辅助弹簧圈栓塞可以达到很高的技术成功率,但不良事件似乎更为常见,临床结果可能比没有支架辅助的结果更差。血栓栓塞并发症似乎得到了很好的控制。虽然不知道放置 EVD 的总数,但报告的 EVD 相关出血并发症并不常见。